HomeTimeline

The Perimenopause Timeline

Perimenopause is not a single event — it's a decade-long transition with distinct stages. Different symptoms appear at different times, and understanding the staging can help you make sense of where you are.

Based on the STRAW+10 staging criteria — the international scientific consensus framework for classifying reproductive ageing, developed through the Stages of Reproductive Aging Workshop. Symptoms and timing shown are from the SWAN longitudinal study (26 years, multiethnic, 3,000+ women).

At a glance

Late Reproductive Years
Mid-30s to early 40s
Early Perimenopause
Early–mid 40s (average 47)
Late Perimenopause
Mid–late 40s to early 50s
Menopause
Average age 51 (range 45–55); premature ovarian insufficiency (POI) defined as menopause before age 40 affects ~1% of women
Early Postmenopause
Years 1–6 after final period
Late Postmenopause
6+ years after final period
Stage 1

Late Reproductive Years

Everything feels normal but changes are beginning

Mid-30s to early 40s
Lab: AMH starts to fall; FSH still normal

What is happening

Your cycles are still regular, but ovarian reserve is quietly declining. Most women feel completely normal. AMH (a marker of egg reserve) begins to drop, and FSH may start to creep up on early-cycle tests.

Symptoms at this stage

  • Cycles may shorten slightly
  • PMS may intensify
  • Fertility begins to decline
Stage 2

Early Perimenopause

Cycles become unpredictable

Early–mid 40s (average 47)
Lab: FSH rising; estradiol variable (can be high or low)

What is happening

The first clinical sign: cycles begin to vary by 7 or more days compared to your usual pattern. You may notice your cycle shortening (25 days instead of 28) or lengthening. Hormones are fluctuating, not simply declining — estrogen can surge higher than normal before eventually dropping, which is why symptoms feel erratic.

Symptoms at this stage

  • Irregular cycle length
  • Heavier or lighter periods
  • Sleep disruption begins
  • Mood changes or increased anxiety
  • Cognitive complaints begin (brain fog, word-finding)
  • Hot flashes may begin (earlier in some women)
Stage 3

Late Perimenopause

The most symptomatic phase for most women

Mid–late 40s to early 50s
Lab: FSH significantly elevated; estradiol low and erratic; AMH very low

What is happening

Cycles now skip entirely — 60+ day gaps signal you've entered late perimenopause. This is when most women experience the most intense symptoms. Estrogen is no longer reliably produced, and the cascade of effects becomes more pronounced. Bone loss is accelerating. Depression risk is at its highest. Hot flashes typically peak here.

Symptoms at this stage

  • Hot flashes and night sweats (peak intensity)
  • Periods skipping — gaps of 60 days or more
  • Sleep significantly disrupted
  • Mood and anxiety at their most unstable
  • Bone loss accelerating (often silently)
  • Cardiovascular changes beginning
  • Vaginal dryness may begin
  • Cognitive symptoms present for many women
Stage 4

Menopause

A single point in time, not a phase

Average age 51 (range 45–55); premature ovarian insufficiency (POI) defined as menopause before age 40 affects ~1% of women
Lab: FSH typically >30 IU/L; estradiol typically <30 pg/mL (thresholds are approximate — lab ranges vary)

What is happening

Menopause is defined retrospectively — it's the point 12 months after your final period. You only know you've reached it by looking back. It's not a phase; it's a marker. The symptoms you've been experiencing don't suddenly stop here.

Symptoms at this stage

  • Defined as 12 consecutive months without a period
  • All perimenopausal symptoms may still be present
Stage 5

Early Postmenopause

Stabilisation — but some symptoms worsen

Years 1–6 after final period
Lab: FSH persistently elevated; estradiol consistently low

What is happening

For many women, hot flashes and mood gradually improve. But other symptoms — particularly vaginal dryness, bladder changes, and cardiovascular risk — continue to worsen without treatment. Bone loss, while slowing from its peak, remains elevated. This window is critical for establishing long-term bone and cardiovascular health.

Symptoms at this stage

  • Vasomotor symptoms gradually improving for many
  • GSM (vaginal/bladder symptoms) worsening without treatment
  • Cardiovascular risk increasing
  • Bone density continuing to decline (more slowly)
  • Cognitive symptoms often improving
  • Metabolic changes (insulin resistance, visceral fat) progressing
Stage 6

Late Postmenopause

A new hormonal baseline

6+ years after final period
Lab: Stable low estrogen; FSH remains elevated

What is happening

The body has adjusted to lower estrogen levels. Most acute symptoms (hot flashes, mood instability) have resolved for the majority of women. The focus shifts to long-term health: bone density maintenance, cardiovascular health, cognitive health, and managing GSM. The benefit of intervening early (during perimenopause) is clearest here.

Symptoms at this stage

  • Hot flashes resolved for most women (25% still symptomatic)
  • GSM the dominant ongoing complaint without treatment
  • Long-term bone, cardiovascular, and metabolic health the priority
⚠️ Why many women are diagnosed late

The gap between early perimenopause and getting a diagnosis

🔬

Normal bloods ≠ no perimenopause

In early perimenopause, hormone levels fluctuate wildly — estrogen can be abnormally high on one test, low on the next. A single “normal” FSH or estradiol, taken on the wrong day, is not a reliable reassurance. Many women are dismissed on this basis alone.

🧠

Mood and brain fog come first

For many women, mood instability, anxiety, and cognitive symptoms precede hot flashes by years. These get labelled as stress, burnout, or new-onset anxiety disorder. Without the “classic” hot flash presentation, the hormonal cause is missed.

⏱️

The window closes while waiting

Bone loss, cardiovascular change, and the peak depression window all occur in late perimenopause. Women who spend years seeking a diagnosis miss the period when early intervention is most protective. Diagnosis timing has direct health consequences — not just quality-of-life ones.

The STRAW+10 criteria exist precisely for this reason. Staging is based on cycle pattern changes, not hormone levels alone. A woman whose cycles have been varying by 7+ days for two consecutive cycles meets the clinical definition of early perimenopause — regardless of what a single hormone test shows. Harlow et al., Menopause (2012) ↗

The most important thing to understand about timing

Late perimenopause is the critical window. This is when symptoms are usually most intense, bone loss is accelerating fastest, depression risk is highest, and cardiovascular changes are beginning — often simultaneously.

Most women reach late perimenopause somewhere between ages 48 and 52, but there is wide variation. The staging criteria (STRAW+10) uses cycle changes as markers, not age.

Timing of treatment matters.Hormone therapy started in early-to-late perimenopause has different effects than the same therapy started 10 years after menopause. The “timing hypothesis” in cardiovascular and cognitive research makes this explicit.

Many women are not diagnosed until late perimenopause or beyond — partly because symptoms like mood changes, joint pain, and brain fog are not recognised as perimenopausal.